Description
Cayman’s medicinal and computational chemistry services, supported by structure-based drug design (SBDD) and computer-aided drug design (CADD), offer a fully integrated, multidisciplinary approach to developing a wide range of therapeutics. Our scientists have the expertise and technology to bring your drug discovery program through preclinical stages of development. Whether it’s hit identification, lead generation or optimization, route and methods development, screening, or scale-up, Cayman’s experienced medicinal chemists, structural biologists, and biochemists possess the skills to accelerate your preclinical drug discovery programs.
Hit Identification- Virtual High-Throughput Screening (vHTS)
- MM-GBSA & FEP
Hit-to-Lead Optimization- Custom Synthesis & Parallel Library Generation
- SAR & Lead Optimization
Process Scaling- -Route Optimization & Scale-Up
- -Pre-GMP Process Development